MANNKIND CORP Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MANNKIND CORP stock issued during period, value, stock options exercised for the quarter ending 2019-09-30 was $31.00K, a 1450.00% increase year-over-year.
- MANNKIND CORP stock issued during period, value, stock options exercised for the quarter ending 2019-06-30 was $15.00K, a 650.00% increase year-over-year.
- MANNKIND CORP stock issued during period, value, stock options exercised for the quarter ending 2019-03-31 was $3.00K.
- MANNKIND CORP stock issued during period, value, stock options exercised for the quarter ending 2018-09-30 was $2.00K.
- MANNKIND CORP stock issued during period, value, stock options exercised for fiscal 2019 was $124.00K, a 1671.43% increase from fiscal 2018.
- MANNKIND CORP stock issued during period, value, stock options exercised for fiscal 2018 was $7.00K, a 70.83% decline from fiscal 2017.
- MANNKIND CORP stock issued during period, value, stock options exercised for fiscal 2017 was $24.00K, a 94.86% decline from fiscal 2016.
- MANNKIND CORP stock issued during period, value, stock options exercised for fiscal 2016 was $467.00K, a 85.67% decline from fiscal 2015.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2019-12-31 | $124.00K 10-K · filed 2021-02-25 | |
| 2019-09-30 | $31.00K 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $15.00K 10-Q · filed 2019-11-08 | |
| 2019-03-31 | $3.00K 10-Q · filed 2019-11-08 | |
| 2018-12-31 | $7.00K 10-K · filed 2020-02-25 | |
| 2018-09-30 | $2.00K 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $2.00K 10-Q · filed 2019-11-08 | |
| 2017-12-31 | $24.00K 10-K · filed 2019-02-26 | |
| 2016-12-31 | $467.00K 10-K · filed 2019-02-26 | |
| 2015-12-31 | $3.26M 10-K · filed 2018-02-27 | |
| 2014-12-31 | $10.98M 10-K · filed 2017-03-16 | |
| 2013-12-31 | $2.27M 10-K · filed 2016-03-15 | |
| 2012-12-31 | $9.00K 10-K · filed 2015-03-02 | |
| 2011-12-31 | $628.00K 10-K · filed 2014-03-03 | |
| 2010-12-31 | $924.00K 10-K · filed 2014-03-03 | |
| 2009-12-31 | $383.00K 10-K · filed 2014-03-03 | |
| 2007-12-31 | $4.92M 10-K · filed 2014-03-03 | |
| 2006-12-31 | $2.31M 10-K · filed 2014-03-03 | |
| 2005-12-31 | $1.95M 10-K · filed 2014-03-03 | |
| 2004-12-31 | $1.08M 10-K · filed 2014-03-03 | |
| 2001-12-31 | $13.00K 10-K · filed 2014-03-03 | |
| 1998-12-31 | $25.00K 10-K · filed 2014-03-03 | |
| 1997-12-31 | $135.00K 10-K · filed 2014-03-03 | |
| 1996-12-31 | $12.00K 10-K · filed 2014-03-03 | |
| 1995-12-31 | $22.00K 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |